{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T23:09:09Z","timestamp":1771974549856,"version":"3.50.1"},"reference-count":35,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2021,11,15]],"date-time":"2021-11-15T00:00:00Z","timestamp":1636934400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Institutes of Health (NICHD)","award":["R43HD095713"],"award-info":[{"award-number":["R43HD095713"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJNS"],"abstract":"<jats:p>Duchenne muscular dystrophy (DMD) is not currently part of mandatory newborn screening, despite the availability of a test since 1975. In the absence of screening, a DMD diagnosis is often not established in patients until 3\u20136 years of age. During this time, irreversible muscle degeneration takes place, and clinicians agree that the earlier therapy is initiated, the better the long-term outcome. With recent availability of FDA-approved DMD therapies, interest has renewed for adoption by state public health programs, but such implementation is a multiyear process. To speed access to approved therapies, we implemented a unique, hospital-based program offering parents of newborns an optional, supplemental DMD newborn screen (NBS) via a two-tiered approach: utilizing a creatine kinase (CK) enzyme assay coupled with rapid targeted next-generation sequencing (tNGS) for the DMD gene (using a Whole-Exome Sequencing (WES) assay). The tNGS\/WES assay integrates the ability to detect both point mutations and large deletion\/duplication events. This tiered newborn screening approach allows for the opportunity to improve treatment and outcomes, avoid the diagnostic delays, and diminish healthcare disparities. To implement this screening algorithm through hospitals in a way that would ultimately be acceptable to public health laboratories, we chose an FDA-approved CK-MM immunoassay to avoid the risks of false-negative\/-positive results. Because newborn CK values can be affected due to non-DMD-related causes such as birth trauma, a confirmatory repeat CK assay on a later dried blood spot (DBS) collection has been proposed. Difficulties associated with non-routine repeat DBS collection, including the tracking and recall of families, and the potential creation of parental anxiety associated with false-positive results, can be avoided with this algorithm. Whereas a DMD diagnosis is essentially ruled out by the absence of detected DMD sequence abnormalities, a subsequent CK would still be warranted to confirm resolution of the initial elevation, and thus the absence of non-DMD muscular dystrophy or other pathologies. To date, we have screened over 1500 newborns (uptake rate of ~80%) by a CK-MM assay, and reflexed DMD tNGS in 29 of those babies. We expect the experience from this screening effort will serve as a model that will allow further expansion to other hospital systems until a universal public health screening is established.<\/jats:p>","DOI":"10.3390\/ijns7040077","type":"journal-article","created":{"date-parts":[[2021,11,15]],"date-time":"2021-11-15T20:46:47Z","timestamp":1637009207000},"page":"77","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Implementation of Hospital-Based Supplemental Duchenne Muscular Dystrophy Newborn Screening (sDMDNBS): A Pathway to Broadening Adoption"],"prefix":"10.3390","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4326-0609","authenticated-orcid":false,"given":"Richard B.","family":"Parad","sequence":"first","affiliation":[{"name":"Department of Pediatric Newborn Medicine, Brigham & Women\u2019s Hospital, Harvard Medical School, Boston, MA 02115, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yvonne","family":"Sheldon","sequence":"additional","affiliation":[{"name":"Department of Pediatric Newborn Medicine, Brigham & Women\u2019s Hospital, Harvard Medical School, Boston, MA 02115, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9470-6386","authenticated-orcid":false,"given":"Arindam","family":"Bhattacharjee","sequence":"additional","affiliation":[{"name":"NCGM, Inc., Raleigh, NC 27606, USA"},{"name":"ABDX Consulting, LLC, Raleigh, NC 27609, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,11,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.nmd.2014.03.008","article-title":"A Systematic Review and Meta-Analysis on the Epidemiology of Duchenne and Becker Muscular Dystrophy","volume":"24","author":"Mah","year":"2014","journal-title":"Neuromuscul. Disord."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0733-8619(18)30072-0","article-title":"Molecular Diagnosis and Modern Management of Duchenne Muscular Dystrophy","volume":"12","author":"Miller","year":"1994","journal-title":"Neurol. Clin."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/0092-8674(87)90504-6","article-title":"Complete Cloning of the Duchenne Muscular Dystrophy (DMD) cDNA and Preliminary Genomic Organization of the DMD Gene in Normal and Affected Individuals","volume":"50","author":"Koenig","year":"1987","journal-title":"Cell"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1152\/physrev.00028.2001","article-title":"Function and Genetics of Dystrophin and Dystrophin-Related Proteins in Muscle","volume":"82","author":"Blake","year":"2002","journal-title":"Physiol. Rev."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jpeds.2009.02.007","article-title":"Delayed Diagnosis in Duchenne Muscular Dystrophy: Data from the Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet)","volume":"155","author":"Ciafaloni","year":"2009","journal-title":"J. Pediatr."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S1474-4422(03)00585-4","article-title":"Dystrophin and Mutations: One Gene, Several Proteins, Multiple Phenotypes","volume":"2","author":"Muntoni","year":"2003","journal-title":"Lancet Neurol."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Al-Zaidy, S.A., Lloyd-Puryear, M., Kennedy, A., Lopez, V., and Mendell, J.R. (2017). A Roadmap to Newborn Screening for Duchenne Muscular Dystrophy. Int. J. Neonatal Screen., 3.","DOI":"10.3390\/ijns3020008"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/S0960-8966(02)00140-2","article-title":"Survival in Duchenne Muscular Dystrophy: Improvements in Life Expectancy since 1967 and the Impact of Home Nocturnal Ventilation","volume":"12","author":"Eagle","year":"2002","journal-title":"Neuromuscul. Disord."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1136\/jme.2004.008219","article-title":"Newborn Screening: New Developments, New Dilemmas","volume":"31","author":"Kerruish","year":"2005","journal-title":"J. Med. Ethics"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1001\/jamaneurol.2021.1782","article-title":"An Opportune Time for Newborn Screening in Duchenne Muscular Dystrophy","volume":"78","author":"Chrzanowski","year":"2021","journal-title":"JAMA Neurol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Smith, L.D., Bainbridge, M.N., Parad, R.B., and Bhattacharjee, A. (2020). Second Tier Molecular Genetic Testing in Newborn Screening for Pompe Disease: Landscape and Challenges. Int. J. Neonatal Screen., 6.","DOI":"10.3390\/ijns6020032"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"4919","DOI":"10.1016\/j.cell.2021.08.028","article-title":"Directed Evolution of a Family of AAV Capsid Variants Enabling Potent Muscle-Directed Gene Delivery across Species","volume":"184","author":"Tabebordbar","year":"2021","journal-title":"Cell"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1542\/peds.55.1.30","article-title":"Newborn Screening for Duchenne Muscular Dystrophy","volume":"55","author":"Zellweger","year":"1975","journal-title":"Pediatrics"},{"key":"ref_14","first-page":"531","article-title":"Duchenne-type muscular dystrophy: Problems, early diagnosis, early treatment (author\u2019s transl)","volume":"190","author":"Beckmann","year":"1978","journal-title":"Klin. Padiatr."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/S0140-6736(78)91836-6","article-title":"Systematic Neonatal Screening for Duchenne Muscular Dystrophy","volume":"2","author":"Dellamonica","year":"1978","journal-title":"Lancet"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0009-8981(80)90097-2","article-title":"Simple Electrophoretic Technique for Creatine Kinase MM Isozyme in Neonatal Duchenne Muscular Disease Screening Using Dried Blood Samples","volume":"105","author":"Adriaenssens","year":"1980","journal-title":"Clin. Chim. Acta"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0140-6736(89)92170-3","article-title":"Duchenne muscular dystrophy: Neonatal screening and prenatal diagnosis","volume":"1","author":"Plauchu","year":"1989","journal-title":"Lancet"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1136\/adc.54.5.362","article-title":"Creatine Phosphokinase Levels in the Newborn and Their Use in Screening for Duchenne Muscular Dystrophy","volume":"54","author":"Drummond","year":"1979","journal-title":"Arch. Dis. Child."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/jmg.19.1.1","article-title":"Feasibility of Neonatal Screening for Duchenne Muscular Dystrophy","volume":"19","author":"Skinner","year":"1982","journal-title":"J. Med. Genet."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Naylor, E.W., Hoffman, E.P., Paulus-Thomas, J., Wessel, H.B., Reid, K.S., Mitchell, B., and Schmidt, B.J. (1992). Neonatal Screening for Duchenne\/Becker Muscular Dystrophy; Reconsideration Based on Molecular Diagnosis and Potential Therapeutics. Screening, 99\u2013113.","DOI":"10.1016\/0925-6164(92)90002-M"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1089\/gte.1998.2.55","article-title":"Neonatal Screening for Duchenne Muscular Dystrophy: A Novel Semiquantitative Application of the Bioluminescence Test for Creatine Kinase in a Pilot National Program in Cyprus","volume":"2","author":"Drousiotou","year":"1998","journal-title":"Genet. Test."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0140-6736(88)90414-X","article-title":"Gene Studies in Newborn Males with Duchenne Muscular Dystrophy Detected by Neonatal Screening","volume":"2","author":"Greenberg","year":"1988","journal-title":"Lancet"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Orfanos, A.P., and Naylor, E.W. (1984). A Rapid Screening Test for Duchenne Muscular Dystrophy Using Dried Blood Specimens. Clin. Chim. Acta, 267\u2013274.","DOI":"10.1016\/0009-8981(84)90133-5"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/jnnp.27.3.181","article-title":"Serum Enzyme Studies in Muscle Disease. Iii. Serum Creatine Kinase Activity in Relatives of Patients with the Duchenne Type of Muscular Dystrophy","volume":"27","author":"Pearce","year":"1964","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/ana.23528","article-title":"Evidence-Based Path to Newborn Screening for Duchenne Muscular Dystrophy","volume":"71","author":"Mendell","year":"2012","journal-title":"Ann. Neurol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1038\/ejhg.2012.301","article-title":"Newborn Bloodspot Screening for Duchenne Muscular Dystrophy: 21 Years Experience in Wales (UK)","volume":"21","author":"Moat","year":"2013","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1373\/clinchem.2016.268425","article-title":"Characterization of a Blood Spot Creatine Kinase Skeletal Muscle Isoform Immunoassay for High-Throughput Newborn Screening of Duchenne Muscular Dystrophy","volume":"63","author":"Moat","year":"2017","journal-title":"Clin. Chem."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Timonen, A., Lloyd-Puryear, M., Hougaard, D.M., Meri\u00f6, L., M\u00e4kinen, P., Laitala, V., P\u00f6l\u00f6nen, T., Skogstrand, K., Kennedy, A., and Airenne, S. (2019). Duchenne Muscular Dystrophy Newborn Screening: Evaluation of a New GSP\u00ae Neonatal Creatine Kinase-MM Kit in a US and Danish Population. Int. J. Neonatal Screen., 5.","DOI":"10.3390\/ijns5030027"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/nature08250","article-title":"Targeted Capture and Massively Parallel Sequencing of 12 Human Exomes","volume":"461","author":"Ng","year":"2009","journal-title":"Nature"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/gim.2014.117","article-title":"Development of DNA Confirmatory and High-Risk Diagnostic Testing for Newborns Using Targeted next-Generation DNA Sequencing","volume":"17","author":"Bhattacharjee","year":"2015","journal-title":"Genet. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/s41436-020-01058-w","article-title":"Methods and Feasibility Study for Exome Sequencing as a Universal Second-Tier Test in Newborn Screening","volume":"23","author":"Sant","year":"2021","journal-title":"Genet. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/pd.1970040406","article-title":"Creatine Kinase Estimation in Pure Fetal Blood Samples for the Prenatal Diagnosis of Duchenne Muscular Dystrophy","volume":"4","author":"Edwards","year":"1984","journal-title":"Prenat. Diagn."},{"key":"ref_33","unstructured":"Wilson, J.M.G., and Jungner, G. (1968). Principles and Practice of Screening for Disease. World Health Organisation. Public Health Paper No. 34."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Wood, M.F., Hughes, S.C., Hache, L.P., Naylor, E.W., Abdel-Hamid, H.Z., Michael Barmada, M., Dobrowolski, S.F., Stickler, D.E., and Clemens, P.R. (2014). Parental Attitudes toward Newborn Screening for Duchenne\/Becker Muscular Dystrophy and Spinal Muscular Atrophy. Muscle Nerve, 822\u2013828.","DOI":"10.1002\/mus.24100"},{"key":"ref_35","first-page":"100730","article-title":"Aldolase A Deficiency: Report of New Cases and Literature Review","volume":"27","author":"Papadopoulos","year":"2021","journal-title":"Mol. Genet. Metab. Rep."}],"container-title":["International Journal of Neonatal Screening"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2409-515X\/7\/4\/77\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:30:30Z","timestamp":1760167830000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2409-515X\/7\/4\/77"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,15]]},"references-count":35,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["ijns7040077"],"URL":"https:\/\/doi.org\/10.3390\/ijns7040077","relation":{},"ISSN":["2409-515X"],"issn-type":[{"value":"2409-515X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,15]]}}}